Underestimation of the resistance of mycobacterium tuberculosis to second-line drugs by the new GenoType MTBDRsl test

Journal of Molecular Diagnostics

Volumn 15, Issue 1, 2013, Pages 44-50

  Jin, Jialin ^a   Shen, Yaojie ^a,b   Fan, Xiaoping ^a   Diao, Ni ^a   Wang, Feifei ^a   Wang, Sen ^a   Weng, Xinhua ^a   Zhang, Wenhong ^a,b  

^a FUDAN UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ETHAMBUTOL; KANAMYCIN; OFLOXACIN;

ARTICLE; BACTERIUM ISOLATION; DRUG RESISTANT TUBERCULOSIS; DRUG SENSITIVITY; EXTENSIVELY DRUG RESISTANT TUBERCULOSIS; GENE SEQUENCE; GENOTYPE; HEREDITY; HUMAN; LUNG TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN;

MYCOBACTERIUM TUBERCULOSIS;

EID: 84874987329     PISSN: 15251578     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmoldx.2012.08.004     Document Type: Article

References (31)

1. Migliori GB, Dheda K, Centis R, Mwaba P, Bates M, O'Grady J, Hoelscher M, Zumla A: Review of multidrug-resistant and extensively drug-resistant TB: global perspectives with a focus on sub-Saharan Africa. Trop Med Int Health 2010, 15:1052-1066
2. World Health Organization: Multidrug and extensively drug-resistant TB (M/XDR-TB): 2010 global report on surveillance and response. WHO Global Report. Geneva, WHO, 2010
3. Vareldzis BP, Grosset J, de Kantor I, Crofton J, Laszlo A, Felten M, Raviglione MC, Kochi A: Drug-resistant tuberculosis: laboratory issues. World Health Organization recommendations. Tuber Lung Dis 1994, 75:1-7
4. Chan RC, Hui M, Chan EW, Au TK, Chin ML, Yip CK, AuYeang CK, Yeung CY, Kam KM, Yip PC, Cheng AF: Genetic and phenotypic characterization of drug-resistant Mycobacterium tuberculosis isolates in Hong Kong. J Antimicrob Chemother 2007, 59: 866-873
5. Chaoui I, Sabouni R, Kourout M, Jordaan AM, Lahlou O, Elouad R, Akrim M, Victor TC, El Mzibri M: Analysis of isoniazid, streptomycin and ethambutol resistance in Mycobacterium tuberculosis isolates from Morocco. J Infect Dev Ctries 2009, 3:278-284
6. Feuerriegel S, Cox HS, Zarkua N, Karimovich HA, Braker K, Rüsch-Gerdes S, Niemann S: Sequence analyses of just four genes to detect extensively drug-resistant Mycobacterium tuberculosis strains in multidrug-resistant tuberculosis patients undergoing treatment. Antimicrob Agents Chemother 2009, 53:3353-3356
7. Hillemann D, Rüsch-Gerdes S, Richter E: Feasibility of the GenoType MTBDRsl assay for fluoroquinolone, amikacin-capreomycin, and ethambutol resistance testing of Mycobacterium tuberculosis strains and clinical specimens. J Clin Microbiol 2009, 47:1767-1772
8. Kiet VS, Lan NT, An DD, Dung NH, Hoa DV, van Vinh Chau N, Chinh NT, Farrar J, Caws M: Evaluation of the MTBDRsl test for detection of second-line-drug resistance in Mycobacterium tuberculosis. J Clin Microbiol 2010, 48:2934-2939
9. Leung KL, Yip CW, Yeung YL, Wong KL, Chan WY, Chan MY, Kam KM: Usefulness of resistant gene markers for predicting treatment outcome on second-line anti-tuberculosis drugs. J Appl Microbiol 2010, 109:2087-2094
10. Lin H, Liu J, Chen L, Jing KH, Shen J, Zhan J, Li YF, Xu RF, Xiong HY, Cao J: [Molecular characterization of embB306 gene in Mycobacterium tuberculosis isolates from tuberculosis patients in Chongqing municipality]. Chinese. Zhonghua Yu Fang Yi Xue Za Zhi 2009, 43:223-226
11. Mokrousov I, Otten T, Manicheva O, Potapova Y, Vishnevsky B, Narvskaya O, Rastogi N: Molecular characterization of ofloxacinresistant Mycobacterium tuberculosis strains from Russia. Antimicrob Agents Chemother 2008, 52:2937-2939
12. Perdigão J, Macedo R, Ribeiro A, Brum L, Portugal I: Genetic characterisation of the ethambutol resistance-determining region in Mycobacterium tuberculosis: prevalence and significance of embB306 mutations. Int J Antimicrob Agents 2009, 33:334-338
13. Starks AM, Gumusboga A, Plikaytis BB, Shinnick TM, Posey JE: Mutations at embB codon 306 are an important molecular indicator of ethambutol resistance in Mycobacterium tuberculosis. Antimicrob Agents Chemother 2009, 53:1061-1066
14. Campbell PJ, Morlock GP, Sikes RD, Dalton TL, Metchock B, Starks AM, Hooks DP, Cowan LS, Plikaytis BB, Posey JE: Molecular detection of mutations associated with first-and second-line drug resistance compared with conventional drug susceptibility testing of Mycobacterium tuberculosis. Antimicrob Agents Chemother 2011, 55: 2032-2041
15. Chang KC, Yew WW, Chan RC: Rapid assays for fluoroquinolone resistance in Mycobacterium tuberculosis: a systematic review and meta-analysis. J Antimicrob Chemother 2010, 65:1551-1561
16. Von Groll A, Martin A, Jureen P, Hoffner S, Vandamme P, Portaels F, Palomino JC, da Silva PA: Fluoroquinolone resistance in Mycobacterium tuberculosis and mutations in gyrA and gyrB. Antimicrob Agents Chemother 2009, 53:4498-4500
17. Yin X, Yu Z: Mutation characterization of gyrA and gyrB genes in levofloxacin-resistant Mycobacterium tuberculosis clinical isolates from Guangdong Province in China. J Infect 2010, 61:150-154
18. Zhang Y, Yew WW: Mechanisms of drug resistance in Mycobacterium tuberculosis. Int J Tuberc Lung Dis 2009, 13:1320-1330
19. Stop TB Partnership, Retooling Task Force; World Health Organization: New Laboratory Diagnostic Tools for TB Control. Geneva, WHO, 2008
20. van Ingen J, Simons S, de Zwaan R, van der Laan T, Kamst-van Agterveld M, Boeree MJ, van Soolingen D: Comparative study on genotypic and phenotypic second-line drug resistance testing of Mycobacterium tuberculosis complex isolates. J Clin Microbiol 2010, 48: 2749-2753
21. Ling DI, Zwerling AA, Pai M: GenoType MTBDR assays for the diagnosis of multidrug-resistant tuberculosis: a meta-analysis. Eur Respir J 2008, 32:1165-1174
22. Yang Y, Li X, Zhou F, Jin Q, Gao L: Prevalence of drug-resistant tuberculosis in mainland China: systematic review and meta-analysis. PLoS One 2011, 6:e20343
23. Marks J: A system for the examination of tubercle bacilli and other mycobacteria. Tubercle 1976, 57:207-225
24. Laszlo A, Rahman M, Espinal M, Raviglione M, WHO/IUATLD Network of Supranational Reference Laboratories: Quality assurance programme for drug susceptibility testing of Mycobacterium tuberculosis in the WHO/IUATLD Supranational Reference Laboratory Network: five rounds of proficiency testing, 1994-1998. Int J Tuberc Lung Dis 2002, 6:748-756
25. Weniger T, Krawczyk J, Supply P, Niemann S, Harmsen D: MIRUVNTRplus: a web tool for polyphasic genotyping of Mycobacterium tuberculosis complex bacteria. Nucleic Acids Res 2010, 38(Web Server issue):W326-W331
26. Allix-Béguec C, Harmsen D, Weniger T, Supply P, Niemann S: Evaluation and strategy for use of MIRU-VNTRplus, a multifunctional database for online analysis of genotyping data and phylogenetic identification of Mycobacterium tuberculosis complex isolates. J Clin Microbiol 2008, 46:2692-2699
27. Jin J, Zhang Y, Fan X, Diao N, Shao L, Wang F, Hu P, Wang S, Weng X, Zhang W: Evaluation of the GenoType MTBDRplus assay and identification of a rare mutation for improving MDR-TB detection. Int J Tuberc Lung Dis 2012, 16:521-526
28. Huang WL, Chi TL, Wu MH, Jou R: Performance assessment of the GenoType MTBDRsl test and DNA sequencing for detection of second-line and ethambutol drug resistance among patients infected with multidrug-resistant Mycobacterium tuberculosis. J Clin Microbiol 2011, 49:2502-2508
29. Brossier F, Veziris N, Aubry A, Jarlier V, Sougakoff W: Detection by GenoType MTBDRsl test of complex mechanisms of resistance to second-line drugs and ethambutol in multidrug-resistant Mycobacterium tuberculosis complex isolates. J Clin Microbiol 2010, 48: 1683-1689
30. Hu Y, Hoffner S, Jiang W, Wang W, Xu B: Genetic characterisation of drug-resistant Mycobacterium tuberculosis in rural China: a population-based study. Int J Tuberc Lung Dis 2010, 14:210-216
31. Safi H, Sayers B, Hazbon MH, Alland D: Transfer of embB codon 306 mutations into clinical Mycobacterium tuberculosis strains alters susceptibility to ethambutol, isoniazid, and rifampin. Antimicrob Agents Chemother 2008, 52:2027-2034